Information de reference pour ce titreAccession Number: | 00002142-201708000-00004.
|
Author: | Cline, Brendan MD; Hurwitz, Lynne M. MD; Kim, Charles Y. MD
|
Institution: | Duke University Medical Center, Department of Radiology, Durham, NC.
|
Title: | MR Venography of the Central Veins of the Thorax.[Review]
|
Source: | Topics in Magnetic Resonance Imaging. 26(4):167-174, August 2017.
|
Abstract: | While imaging of the central venous system has traditionally been performed with conventional venography, MR venography (MRV) has emerged as an important modality as techniques and validation studies have evolved over time. While magnetic resonance angiography has a very robust representation in the literature, the proportion representing MRV is relatively sparse. The purpose of this article is to review the indications, techniques, and dedicated studies validating MRV of the central veins of the thorax.
Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.
|
Author Keywords: | central veins; MR venography; venous imaging.
|
References: | 1. Mueller GC, Lu JC, Mahani MG, et al. MR imaging of thoracic veins. Magn Reson Imaging Clin N Am 2015; 23:293-307.
2. Rahmani N, White CS. MR imaging of thoracic veins. Magn Reson Imaging Clin N Am 2008; 16:249-262. viii.
3. Sonavane SK, Milner DM, Singh SP, et al. Comprehensive imaging review of the superior vena cava. Radiographics 2015; 35:1873-1892.
4. White CS. MR imaging of thoracic veins. Magn Reson Imaging Clin N Am 2000; 8:17-32.
5. Levit RD, Cohen RM, Kwak A, et al. Asymptomatic central venous stenosis in hemodialysis patients. Radiology 2006; 238:1051-1056.
6. Parish JM, Marschke RF Jr, Dines DE, et al. Etiologic considerations in superior vena cava syndrome. Mayo Clin Proc 1981; 56:407-413.
7. Lee T, Roy-Chaudhury P. Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis. Adv Chronic Kidney Dis 2009; 16:329-338.
8. United States Renal Data System. 2016 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2016.
9. KDOQI; National Kidney Foundation. Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults. Am J Kidney Dis 2006; 47 (5 suppl 3):S16-S85.
10. Vascular Access Work Group. Clinical practice guidelines for vascular access. Am J Kidney Dis 2006; 48 (suppl 1):S176-S247.
11. Finn JP, Zisk JH, Edelman RR, et al. Central venous occlusion: MR angiography. Radiology 1993; 187:245-251.
12. Davenport MS, Khalatbari S, Dillman JR, et al. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material. Radiology 2013; 267:94-105.
13. McDonald RJ, McDonald JS, Bida JP, et al. Intravenous contrast material-induced nephropathy: causal or coincident phenomenon? Radiology 2013; 267:106-118.
14. Rose SC, Kinney TB, Bundens WP, et al. Importance of Doppler analysis of transmitted atrial waveforms prior to placement of central venous access catheters. J Vasc Interv Radiol 1998; 9:927-934.
15. Ghaye B, Szapiro D, Willems V, et al. Pitfalls in CT venography of lower limbs and abdominal veins. AJR Am J Roentgenol 2002; 178:1465-1471.
16. Singer JR. Blood flow rates by nuclear magnetic resonance measurements. Science 1959; 130:1652-1653.
17. Hansen ME, Spritzer CE, Sostman HD. Assessing the patency of mediastinal and thoracic inlet veins: value of MR imaging. AJR Am J Roentgenol 1990; 155:1177-1182.
18. McMurdo KK, de Geer G, Webb WR, et al. Normal and occluded mediastinal veins: MR imaging. Radiology 1986; 159:33-38.
19. Weinreb JC, Mootz A, Cohen JM. MRI: evaluation of mediastinal and thoracic inlet venous obstruction. AJR Am J Roentgenol 1986; 146:679-684.
20. Hartnell GG, Hughes LA, Finn JP, et al. Magnetic resonance angiography of the central chest veins. A new gold standard? Chest 1995; 107:1053-1057.
21. Rose SC, Gomes AS, Yoon HC. MR angiography for mapping potential central venous access sites in patients with advanced venous occlusive disease. AJR Am J Roentgenol 1996; 166:1181-1187.
22. Grobner T. Gadolinium-a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 2006; 21:1104-1108.
23. Todd DJ, Kay J. Gadolinium-induced fibrosis. Annu Rev Med 2016; 67:273-291.
24. Tomasian A, Lohan DG, Laub G, et al. Noncontrast 3D steady state free precession magnetic resonance angiography of the thoracic central veins using nonselective radiofrequency excitation over a large field of view: initial experience. Invest Radiol 2008; 43:306-313.
25. Krishnam MS, Tomasian A, Deshpande V, et al. Noncontrast 3D steady-state free-precession magnetic resonance angiography of the whole chest using nonselective radiofrequency excitation over a large field of view: comparison with single-phase 3D contrast-enhanced magnetic resonance angiography. Invest Radiol 2008; 43:411-420.
26. Kim CY, Bashir MR, Heye T, et al. Respiratory-gated noncontrast SPACE MR angiography sequence at 3T for evaluation of the central veins of the chest: a feasibility study. J Magn Reson Imaging 2015; 41:67-73.
27. Morita S, Kojima S, Hirata M, et al. Unenhanced ECG-gated fast spin-echo MR digital subtraction angiography (MRDSA) using short echo-spacing three-dimensional sequence of femoral arteries: initial experience. J Magn Reson Imaging 2011; 34:157-164.
28. Shinde TS, Lee VS, Rofsky NM, et al. Three-dimensional gadolinium-enhanced MR venographic evaluation of patency of central veins in the thorax: initial experience. Radiology 1999; 213:555-560.
29. Thornton MJ, Ryan R, Varghese JC, et al. A three-dimensional gadolinium-enhanced MR venography technique for imaging central veins. AJR Am J Roentgenol 1999; 173:999-1003.
30. Tanju S, Sancak T, Dusunceli E, et al. Direct contrast-enhanced 3D MR venography evaluation of upper extremity deep venous system. Diagn Interv Radiol 2006; 12:74-79.
31. Oxtoby JW, Widjaja E, Gibson KM, et al. 3D gadolinium-enhanced MRI venography: evaluation of central chest veins and impact on patient management. Clin Radiol 2001; 56:887-894.
32. Gao K, Jiang H, Zhai RY, et al. Three-dimensional gadolinium-enhanced MR venography to evaluate central venous steno-occlusive disease in hemodialysis patients. Clin Radiol 2012; 67:560-563.
33. Edelman RR, Wentz KU, Mattle H, et al. Projection arteriography and venography: initial clinical results with MR. Radiology 1989; 172:351-357.
34. Lebowitz JA, Rofsky NM, Krinsky GA, et al. Gadolinium-enhanced body MR venography with subtraction technique. AJR Am J Roentgenol 1997; 169:755-758.
35. Ruehm SG, Zimny K, Debatin JF. Direct contrast-enhanced 3D MR venography. Eur Radiol 2001; 11:102-112.
36. Pagnan L, Tona G, Belgrano M, et al. Direct contrast enhanced MR in the study of central venous accesses in children receiving total parenteral nutrition. Radiol Med 2005; 110:241-248.
37. Kim CY, Merkle EM. Time-resolved MR angiography of the central veins of the chest. AJR Am J Roentgenol 2008; 191:1581-1588.
38. Bremerich J, Bilecen D, Reimer P. MR angiography with blood pool contrast agents. Eur Radiol 2007; 17:3017-3024.
39. Frydrychowicz A, Russe MF, Bock J, et al. Comparison of gadofosveset trisodium and gadobenate dimeglumine during time-resolved thoracic MR angiography at 3T. Acad Radiol 2010; 17:1394-1400.
40. Akesson M, Lehti L, Hoglund P, et al. Thoracic magnetic resonance venography using Gadofosveset in patients with venous pathology-A comparative study of image quality and inter-rater variability. Phlebology 2016; [Epub ahead of print].
41. Kim CY, Heye T, Bashir MR, et al. Gadofosveset-enhanced magnetic resonance angiography of the thoracic vasculature in the equilibrium phase: feasibility and impact of dose. J Comput Assist Tomogr 2013; 37:732-736.
42. Ablavar Package Insert. Billerica, MA, USA: Lantheus Medical Imaging, Inc.
43. Bashir MR, Mody R, Neville A, et al. Retrospective assessment of the utility of an iron-based agent for contrast-enhanced magnetic resonance venography in patients with endstage renal diseases. J Magn Reson Imaging 2014; 40:113-118.
44. Luhar A, Khan S, Finn JP, et al. Contrast-enhanced magnetic resonance venography in pediatric patients with chronic kidney disease: initial experience with ferumoxytol. Pediatr Radiol 2016; 46:1332-1340.
45. Schmitz SA, Winterhalter S, Schiffler S, et al. USPIO-enhanced direct MR imaging of thrombus: preclinical evaluation in rabbits. Radiology 2001; 221:237-243.
|
Language: | English.
|
Document Type: | Review Articles.
|
Journal Subset: | Clinical Medicine. Health Professions.
|
ISSN: | 1536-1004
|
NLM Journal Code: | aod, 8913523
|
DOI Number: | https://dx.doi.org/10.1097/RMR.0...- ouverture dans une nouvelle fenêtre
|
Annotation(s) | |
|
|